Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company said that it plans to focus first on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications. Its team is composed of machine learning experts with decade of experience in building large scale ML systems for computational pathology. They develop novel deep learning and ensemble models to create the first clinical-grade AI in pathology.

Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company said that it plans to focus first on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications. Its team is composed of machine learning experts with decade of experience in building large scale ML systems for computational pathology. They develop novel deep learning and ensemble models to create the first clinical-grade AI in pathology.

EyeArt is the first and only FDA-cleared AI technology for autonomous detection of both more than mild and vision-threatening diabetic retinopathy. The EyeArt® AI Eye Screening System is the most extensively validated autonomous AI technology, tested on over half a million patient visits globally with over two million images collected in real-world clinical environments.It is proven to be safe, fast, and consistent.